+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Mesothelioma"

Malignant Mesothelioma - Global Strategic Business Report - Product Thumbnail Image

Malignant Mesothelioma - Global Strategic Business Report

  • Report
  • April 2024
  • 193 Pages
  • Global
From
Oncology. Edition No. 1. Mount Sinai Expert Guides - Product Thumbnail Image

Oncology. Edition No. 1. Mount Sinai Expert Guides

  • Book
  • October 2019
  • 632 Pages
Oncology. Edition No. 3. Lecture Notes - Product Thumbnail Image

Oncology. Edition No. 3. Lecture Notes

  • Book
  • January 2016
  • 368 Pages
  • 10 Results (Page 1 of 1)
Loading Indicator

Mesothelioma is a rare form of cancer that affects the mesothelial cells of the body, most commonly the lungs and abdomen. It is caused by exposure to asbestos, a mineral fiber used in many industries. Treatment for mesothelioma is typically multimodal, involving surgery, chemotherapy, and radiation. Mesothelioma is a relatively small market within the larger oncology space. It is estimated that there are approximately 3,000 new cases of mesothelioma diagnosed in the United States each year. Despite its small size, the mesothelioma market is highly competitive, with a number of companies offering treatments and services. Some of the companies in the mesothelioma market include Bristol-Myers Squibb, Merck, Novartis, Pfizer, and Roche. Additionally, there are a number of smaller companies that specialize in mesothelioma treatments, such as ImmunoCellular Therapeutics, OncoGenex Pharmaceuticals, and ZymoGenetics. Show Less Read more